Dysregulation of sex-steroid receptor functions, including the PR, has been implicated in numerous pathological conditions including cancer, obesity, neuroendocrine disorders, cardiovascular disease, hyperlipidemia, infertility, and other reproductive disorders [reviewed in6,64]. This evidence concerns the gene PGR and obesity due to melanocortin 4 receptor deficiency.